Lillie James Woodruff sold $674K of MPLT
Lillie James Woodruff (Chief Scientific Officer) sold 18,267 shares of MapLight Therapeutics, Inc. (MPLT) at an average of $36.88 ($36.00–$37.96, $0.67M total) across 7 trades over 2026-07-15 to 2026-07-17.
How this was made
The 30-second read
Why it matters
The new information is the disclosed open-market sale amount, share count, and trade dates, which may influence short-term sentiment but does not provide new company performance or guidance.
Market read
Traders may monitor for follow-on insider activity or whether the sale coincides with other catalysts, but the filing alone is unlikely to drive a durable repricing.
What to watch
The article does not state whether the sale was tax-related, planned for liquidity, or paired with any other insider buying, limiting inference from the transaction alone.
Background
The article is an SEC Form 4 insider transaction disclosure for MapLight Therapeutics, Inc., reported by its Chief Scientific Officer.
Ticker impact
MapLight Therapeutics CSO Lillie James Woodruff sold $673,636 of MPLT shares in open-market trades dated July 15 to July 17.
Likely limited, short-lived sentiment impact; any move would be small unless accompanied by other company-specific catalysts.
The filing is a Form 4 insider transaction with a defined sale window and price range, but it provides no new operational, clinical, or financial guidance.
Market effects
No direct sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider sales can be routine liquidity events and are not necessarily bearish, especially without a 10b5-1 plan being cited here.
Key entities
- issuerMapLight Therapeutics, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderLillie James Woodruff
Chief Scientific Officer who sold shares in open-market transactions.